Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

about

Cholinesterases and the fine line between poison and remedy.Special Issue: "Molecules against Alzheimer".

P2860

Q50152965-179D7E0F-E534-4BE7-A56C-9FB084247F4B Q51246809-E7DA0501-473B-483F-8386-B948F2519E75

P2860

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q38751372

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel Selective Butyrylcholine ...... utics for Alzheimer's Disease.

@en

type

Item

label

Novel Selective Butyrylcholine ...... utics for Alzheimer's Disease.

@en

prefLabel

Novel Selective Butyrylcholine ...... utics for Alzheimer's Disease.

@en

P1476

Novel Selective Butyrylcholine ...... eutics for Alzheimer's Disease

@en

P2093

Beata Kling

http://www.w3.org/2001/XMLSchema#string

John F Gilmer

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Jörg Heilmann

http://www.w3.org/2001/XMLSchema#string

Mike Jones

http://www.w3.org/2001/XMLSchema#string

Shona Harmon

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic epidemiology of neurodegenerative disease.

Alzheimer Disease and Oxidative Stress

Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor

The cholinergic hypothesis of geriatric memory dysfunction

Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.

Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.

Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties.

P304

440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES21040440

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299572084

http://www.w3.org/2001/XMLSchema#string

P698

27534722

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

6273432

http://www.w3.org/2001/XMLSchema#string

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

about

P2860

P2860

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932